MK 0518; N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-4-pyrimidinecarboxamide, monopotassium salt
Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM).{26192} It is metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1.{26191} Raltegravir has long-term efficacy and safety in managing HIV-1 infection in adults, children, and adolescents.{26191,26193}
产品描述
A potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM); metabolized primarily by uridine diphosphate glucuronosyltransferase 1A1